Megasoft [MEGASOFT] vs Zim Laboratories [ZIMLAB] Detailed Stock Comparison
Megasoft
NSE
Loading...
Zim Laboratories
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Megasoft wins in 8 metrics, Zim Laboratories wins in 9 metrics, with 0 ties. Zim Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Megasoft | Zim Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 6.79 | 39.07 | Megasoft |
| Price-to-Book Ratio | 7.58 | 1.46 | Zim Laboratories |
| Debt-to-Equity Ratio | 96.55 | 46.70 | Zim Laboratories |
| PEG Ratio | -0.01 | -0.13 | Zim Laboratories |
| EV/EBITDA | 7.94 | 13.36 | Megasoft |
| Profit Margin (TTM) | 69.03% | 2.55% | Megasoft |
| Operating Margin (TTM) | 90.92% | -0.84% | Megasoft |
| EBITDA Margin (TTM) | 90.92% | N/A | N/A |
| Return on Equity | -20.84% | 4.82% | Zim Laboratories |
| Return on Assets (TTM) | -8.22% | 2.58% | Zim Laboratories |
| Free Cash Flow (TTM) | $194.75M | $3.57M | Megasoft |
| 1-Year Return | 139.49% | -24.74% | Megasoft |
| Price-to-Sales Ratio (TTM) | 6.17 | 1.00 | Zim Laboratories |
| Enterprise Value | $12.26B | $4.84B | Megasoft |
| EV/Revenue Ratio | 6.88 | 1.31 | Zim Laboratories |
| Gross Profit Margin (TTM) | N/A | 58.18% | N/A |
| Revenue per Share (TTM) | $24 | $76 | Zim Laboratories |
| Earnings per Share (Diluted) | $21.89 | $1.94 | Megasoft |
| Beta (Stock Volatility) | 1.05 | 0.38 | Zim Laboratories |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Megasoft vs Zim Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Megasoft | 3.41% | 7.28% | 23.83% | 83.23% | 210.11% | 86.75% |
| Zim Laboratories | 0.85% | -0.57% | 1.76% | -33.07% | -26.20% | -26.20% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Megasoft | 139.49% | 341.23% | 2,136.19% | 3,324.17% | 375.72% | 14.18% |
| Zim Laboratories | -24.74% | -24.74% | -24.74% | -24.74% | -24.74% | -24.74% |
News Based Sentiment: Megasoft vs Zim Laboratories
Megasoft
News based Sentiment: POSITIVE
Megasoft demonstrated a significant financial turnaround in September, moving from losses to profits and receiving a 'Strong Buy' recommendation from analysts. While some price volatility occurred, the overall trend is positive, indicating a potential shift in the company's fortunes and making it a noteworthy month for investors.
Zim Laboratories
News based Sentiment: NEGATIVE
September brought a series of negative developments for Zim Laboratories, including a net loss, revenue decline, and a significant drop in stock price. These factors, combined with previous analyst warnings, create a concerning investment picture and warrant a cautious approach.
Performance & Financial Health Analysis: Megasoft vs Zim Laboratories
| Metric | MEGASOFT | ZIMLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹11.08B | ₹3.69B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 190,597 | 54,401 |
| 90 Day Avg. Volume | 203,876 | 162,663 |
| Last Close | ₹169.96 | ₹75.87 |
| 52 Week Range | ₹49.06 - ₹172.57 | ₹69.10 - ₹128.00 |
| % from 52W High | -1.51% | -40.73% |
| All-Time High | ₹172.57 (Sep 23, 2025) | ₹127.00 (Jul 18, 2025) |
| % from All-Time High | -1.51% | -40.26% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | -0.12% |
| Quarterly Earnings Growth | N/A | -0.12% |
| Financial Health | ||
| Profit Margin (TTM) | 0.69% | 0.03% |
| Operating Margin (TTM) | 0.91% | -0.01% |
| Return on Equity (TTM) | -0.21% | 0.05% |
| Debt to Equity (MRQ) | 96.55 | 46.70 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹19.63 | ₹51.77 |
| Cash per Share (MRQ) | ₹1.29 | ₹0.42 |
| Operating Cash Flow (TTM) | ₹-492,054,000 | ₹201.64M |
| Levered Free Cash Flow (TTM) | ₹-299,374,000 | ₹121.65M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Megasoft vs Zim Laboratories
| Metric | MEGASOFT | ZIMLAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 6.79 | 39.07 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.01 | -0.13 |
| Price to Sales (TTM) | 6.17 | 1.00 |
| Price to Book (MRQ) | 7.58 | 1.46 |
| Market Capitalization | ||
| Market Capitalization | ₹11.08B | ₹3.69B |
| Enterprise Value | ₹12.26B | ₹4.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.88 | 1.31 |
| Enterprise to EBITDA | 7.94 | 13.36 |
| Risk & Other Metrics | ||
| Beta | 1.05 | 0.38 |
| Book Value per Share (MRQ) | ₹19.63 | ₹51.77 |
Financial Statements Comparison: Megasoft vs Zim Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MEGASOFT | ZIMLAB |
|---|---|---|
| Revenue/Sales | ₹0 | ₹717.56M |
| Cost of Goods Sold | ₹0 | ₹300.09M |
| Gross Profit | ₹0 | ₹417.47M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-168.12M | ₹-6.05M |
| EBITDA | ₹-131.33M | ₹57.35M |
| Pre-Tax Income | ₹1.67B | ₹-24.32M |
| Income Tax | ₹310.00M | ₹-5.57M |
| Net Income (Profit) | ₹1.36B | ₹-18.75M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MEGASOFT | ZIMLAB |
|---|---|---|
| Cash & Equivalents | ₹91.70M | ₹19.47M |
| Total Current Assets | ₹560.34M | ₹2.31B |
| Total Current Liabilities | ₹683.12M | ₹1.66B |
| Long-Term Debt | ₹1.30B | ₹423.71M |
| Total Shareholders Equity | ₹1.44B | ₹2.52B |
| Retained Earnings | ₹348.54M | ₹1.69B |
| Property, Plant & Equipment | ₹2.00B | ₹139.15M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MEGASOFT | ZIMLAB |
|---|---|---|
| Operating Cash Flow | N/A | ₹-59.64M |
| Capital Expenditures | N/A | ₹-2.56M |
| Free Cash Flow | N/A | ₹-5.43M |
| Debt Repayment | N/A | ₹-4.02M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MEGASOFT | ZIMLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 190,597 | 54,401 |
| Average Daily Volume (90 Day) | 203,876 | 162,663 |
| Shares Outstanding | 73.77M | 48.73M |
| Float Shares | 42.39M | 13.62M |
| % Held by Insiders | 0.41% | 0.70% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Megasoft vs Zim Laboratories
| Metric | MEGASOFT | ZIMLAB |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |